PROVIDER PROFILE · NPI 1295042471

Hemanth HampoleM.D.

PRACTICERAHUL PRAKASH, M.D., P.A.See all providers at this practice →

Internal MedicineKaty, TXI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

965

Unique beneficiaries

—

Total services

7,639

Distinct HCPCS

Medicare payment

$298K

Peer benchmark

Total Medicare services vs. 6,183 Internal Medicine providers in TX — top quintile (cohort median 673).

PRESCRIBING · PART D · 2024

Total Rx claims

746

Beneficiaries

—

Total drug cost

$151K

Distinct drugs

Brand share

24.1%

Top prescribed drugs

Dapagliflozin Propanediol132 claims

Furosemide103 claims

Carvedilol73 claims

Lisinopril60 claims

Amlodipine Besylate44 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$2K

Payment records

By payment type

Food and Beverage$1K

Travel and Lodging$296

Education$9

FACILITY AFFILIATIONS

Hospital & Facility Affiliations (8)

Dialysis facility

Dialysis facility

Dialysis facility

Dialysis facility

Hospital

Hospital

Hospital

Inpatient rehabilitation facility

REFERRAL NETWORK

Where Hemanth Hampole's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 0 inbound referrers · 2 outbound destinations.

Receives referrals from

Inbound — who sends patients here

No inbound pairs above the suppression threshold.

Refers patients to

Outbound — where patients go next

Physician	Patients	Visits
THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS	27	100
James Lash Nephrology · Chicago, IL	13	26

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history